Call Us Today!

+66 0 2 683 0291

<br>

Canadian Sites Approved for Phase 3 Clinical Trial of WF10

OXO Chemie AG of Switzerland announced today the April 6 approval by the Health Protection Branch for the initiation of Canadian



Read More About

How to Order

How to Order

Get all your questions answered about ordering Immunokine® WF10 (i.v. Solution)

Publications

Publications

Register to get access information to all Publications related to the development of Immunokine® WF10 (i.v. Solution)